NCT/Study#
N/A /
MOFFIT-CHIMERIC
Characteristics and Outcomes of Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T Cell Therapy”
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
